Loading
This page follows insider dealings at טבע as filed with TASE (ISA). From 18 October 2025 to 18 October 2026, the disclosure feed for טבע logged 18 filings by 14 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of טבע stock was filed.
Across the 530 companies tracked on its exchange, the median is 13 filings; at 18 filings, this issuer sits above that mark.
Source: insider filings from TASE (ISA). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
18 of 18 declarations
Teva is an Israeli pharmaceutical company specializing in the production of generic and branded medications. It is listed on the Tel Aviv Stock Exchange.